GSK sold the 5.4ha site to Hadley in 2021 and announced its plans to fully vacate the building by 2024, relocating all staff to a new Apt-designed building in London’s New Oxford Street. Hadley took ...

Drugs giant GlaxoSmithKline (GSK) is launching a development plan that is set to create up to 5,000 new jobs. The company is looking to extend its facility in Stevenage, Hertfordshire, where it ...

A high-profile team of architects, landscape designers, and consultants has been appointed to progress a masterplan for the redevelopment of the former GSK headquarters at 980 Great West Road, ...

Taryn Paehr says that even in her earliest days as a student intern with GlaxoSmithKline Inc. (GSK), she realized the biopharmaceutical company offered the sort of workplace where she could grow ...

In addition to established platform technologies, GSK is building new platforms such as the Multiple Antigen-Presenting System (MAPS) and mRNA, key to addressing the most complex diseases.

Building this trust among employees involves ... is aiming to “do the right thing” for wider society. With the new goals, GSK aims to have a net zero impact on climate and a net positive ...

with the goal being to identify and validate new targets for Alzheimer’s drugs. GSK agreed to give Muna 33.5 million euros, or roughly $35 million, up front, plus as much as 140 million euros in ...